Routine use of fluoroscopic guidance and up-front femoral angiography results in reduced femoral complications in patients undergoing coronary angiographic procedures: an observational study using an Interrupted Time-Series analysis.
Aged
Coronary Angiography
/ methods
Coronary Artery Disease
/ diagnosis
Female
Femoral Artery
Fluoroscopy
/ methods
Follow-Up Studies
Humans
Incidence
Male
Percutaneous Coronary Intervention
/ methods
Prospective Studies
Risk Factors
Surgery, Computer-Assisted
/ methods
Time Factors
United Kingdom
/ epidemiology
Vascular System Injuries
/ epidemiology
Femoral access
Femoral angiography
Fluoroscopy
Percutaneous coronary intervention
Journal
Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
23
06
2018
accepted:
14
09
2018
pubmed:
29
9
2018
medline:
19
3
2019
entrez:
29
9
2018
Statut:
ppublish
Résumé
Transradial access is increasingly used for coronary angiography and percutaneous coronary intervention, however, femoral access remains necessary for numerous procedures, including complex high-risk interventions, structural procedures, and procedures involving mechanical circulatory support. Optimising the safety of this approach is crucial to minimize costly and potentially life-threatening complications. We initiated a quality improvement project recommending routine fluoroscopic guidance (femoral head), and upfront femoral angiography should be performed to assess for location and immediate complications. We assessed the effect of these measures on the rate of vascular complications. Data were collected prospectively on 4534 consecutive patients undergoing femoral coronary angiographic procedures from 2015 to 2017. The primary end-point was any access complication. Outcomes were compared pre and post introduction including the use of an Interrupted Time-Series (ITS) analysis. 1890 patients underwent angiography prior to the introduction of routine fluoroscopy and upfront femoral angiography and 2644 post. All operators adopted these approaches. Baseline characteristics, including large sheath use, anticoagulant use and PCI rates were similar between the 2 groups. Fluoroscopy-enabled punctures were made in the 'safe zone' in over 91% of cases and upfront femoral angiography resulted in management changes i.e. procedural abandonment prior to heparin administration in 21 patients (1.1%). ITS analysis demonstrated evidence of a reduction in femoral complication rates after the introduction of the intervention, which was over and above the existing trend before the introduction (40% decrease RR 0.58; 95% CI: 0.25-0.87; P < 0.01). Overall these quality improvement measures were associated with a significantly lower incidence of access site complications (0.9% vs. 2.0%, P < 0.001). Routine fluoroscopy guided vascular access and upfront femoral angiography prior to anticoagulation leads to lower vascular complication rates. Thus, study shows that femoral intervention can be performed safely with very low access-related complication rates when fluoroscopic guidance and upfront angiography is used to obtain femoral arterial access.
Identifiants
pubmed: 30264266
doi: 10.1007/s00380-018-1266-6
pii: 10.1007/s00380-018-1266-6
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
419-426Subventions
Organisme : Department of Health
ID : DRF-2014-07-008
Pays : United Kingdom
Organisme : Department of Health
ID : PB-PG-1216-20028
Pays : United Kingdom
Références
J Clin Pharm Ther. 2002 Aug;27(4):299-309
pubmed: 12174032
Cathet Cardiovasc Diagn. 1975;1(1):35-45
pubmed: 1222406
Ann Vasc Surg. 2010 Apr;24(3):328-35
pubmed: 19748217
JACC Cardiovasc Interv. 2009 Nov;2(11):1047-54
pubmed: 19926042
JACC Cardiovasc Interv. 2010 Jul;3(7):751-8
pubmed: 20650437
Catheter Cardiovasc Interv. 2011 Aug 1;78(2):294-9
pubmed: 21413114
Heart. 2011 Aug;97(16):1293-7
pubmed: 21719554
Cardiovasc Interv Ther. 2014 Jan;29(1):18-23
pubmed: 23959379
EuroIntervention. 2014 Feb;9(10):1189-94
pubmed: 24561736
Catheter Cardiovasc Interv. 2014 Jul 1;84(1):62-9
pubmed: 24677734
Postgrad Med J. 2015 Jun;91(1076):343-54
pubmed: 26045562
BMJ. 2015 Jun 09;350:h2750
pubmed: 26058820
J Invasive Cardiol. 2015 Jul;27(7):318-23
pubmed: 26136279
JACC Cardiovasc Interv. 2015 Dec 21;8(14):1854-64
pubmed: 26604063
Heart Lung Circ. 2016 Dec;25(12):1203-1209
pubmed: 27265645
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
Nat Rev Cardiol. 2016 Nov;13(11):641-650
pubmed: 27558003
JACC Cardiovasc Interv. 2017 Apr 10;10(7):635-644
pubmed: 28385401
JACC Cardiovasc Interv. 2017 Nov 27;10(22):2233-2241
pubmed: 29169493
JACC Cardiovasc Interv. 2017 Nov 27;10(22):2269-2279
pubmed: 29169496
JACC Cardiovasc Interv. 2017 Nov 27;10(22):2280-2282
pubmed: 29169497
Catheter Cardiovasc Interv. 2018 Jan 1;91(1):25-26
pubmed: 29314640
J Interv Cardiol. 2018 Aug;31(4):496-503
pubmed: 29372578